ARIAD PHARMACEUTICALS, INC.;ARIAD GENE THERAPEUTICS, INC.

CAMBRIDGE, MA US

1. 20100266590 COMBINATION THERAPY - Disclosed are methods for treating various cancers 10-21-2010
2. 20100247643 Oral formulations - solid pharmaceutical composition containing AP23573 suitable for oral administration is disclosed 09-30-2010
3. 20100197907 Phosphorus-containing compounds & uses thereof 08-05-2010
4. 20090311249 Capecitabine Combination Therapy - The invention provides the use of a combination of an mTOR inhibitor and capecitabine in the treatment of cancer 12-17-2009
5. 20090176781 Acetylenic Heteroaryl Compounds - This invention relates to compounds of the general formula: STR00001 in which the variable groups are as defined 07-09-2009
6. 20090156596 Unsaturated Heterocyclic Derivatives - This invention relates to compounds of the general formula: STR00001 in which the variable groups are as defined 06-18-2009
7. 20090149471 Monocyclic Heterocyclic Compounds - This invention relates to compounds of the general formula: STR00001 in which the variable groups are as defined 06-11-2009
8. 20080207644 Therapeutic materials and methods - Disclosed are methods for treating various cancers 08-28-2008